- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cutaneous T-Cell Lymphoma Refractory
Total 7917 results
-
Mingzhi ZhangUnknownNK/T Cell LymphomaChina
-
Ruijin HospitalUnknownPeripheral T Cell LymphomaChina
-
Guangdong Provincial People's HospitalUnknown
-
The Lymphoma Academic Research OrganisationCompletedPeripheral T Cell LymphomaFrance
-
Eisai Inc.WithdrawnPeripheral T-Cell LymphomaUnited States
-
University of GöttingenCompletedPeripheral T-Cell Lymphoma
-
Chonnam National University HospitalKyungpook National University HospitalUnknownPeripheral T Cell LymphomaKorea, Republic of
-
Samsung Medical CenterAsan Medical Center; Yonsei University; Seoul National University; Chonnam National...CompletedExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeKorea, Republic of
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Zhao WeiliNot yet recruiting
-
Ruijin HospitalRenJi Hospital; West China Hospital; Shandong Provincial Hospital; Tianjin Medical... and other collaboratorsRecruitingPeripheral T Cell LymphomaChina
-
Second Affiliated Hospital, School of Medicine,...Ningbo No. 1 Hospital; Jinhua Central Hospital; Huizhou Municipal Central HospitalRecruiting
-
Shanghai Zhongshan HospitalTakeda; BeiGeneNot yet recruiting
-
Henan Cancer HospitalRecruitingPeripheral T-Cell LymphomaChina
-
Peking UniversityPeking University Cancer Hospital & InstituteNot yet recruitingNK/T Cell LymphomaChina
-
Antengene CorporationRecruitingPeripheral T-cell Lymphoma | NK/T-cell LymphomaChina
-
Genor Biopharma Co., Ltd.RecruitingPeripheral T Cell LymphomaChina
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
University of Colorado, DenverBristol-Myers SquibbActive, not recruitingPeripheral T Cell LymphomaUnited States
-
Conjupro Biotherapeutics, Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Withdrawn
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownPeripheral T Cell Lymphoma
-
Zhejiang Cancer HospitalUnknownPeripheral T Cell LymphomaChina
-
Eisai Co., Ltd.CompletedPeripheral T-Cell LymphomaJapan
-
The University of Hong KongUnknown
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
Nanfang Hospital of Southern Medical UniversityUnknownPeripheral T Cell LymphomaChina
-
Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
Samsung Medical CenterCompleted
-
University Hospital, GrenobleFrench Innovative Leukemia OrganisationCompletedPeripheral T Cell LymphomaFrance
-
Mahidol UniversityBayerTerminatedPeripheral T-Cell LymphomaThailand
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Burkitt Lymphoma | Secondary... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | B-Cell Non-Hodgkin Lymphoma | Metastatic Pancreatic Carcinoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Pancreatic Carcinoma | Refractory T-Cell... and other conditionsUnited States
-
Sun Yat-sen UniversityRecruitingExtranodal NK/T-cell LymphomaChina
-
Beijing Tongren HospitalRecruitingExtranodal NK/T-cell LymphomaChina
-
Beijing Tongren HospitalNot yet recruitingExtranodal NK/T-cell Lymphoma
-
Beijing Tongren HospitalRecruitingExtranodal NK/T-cell LymphomaChina
-
ViGenCell Inc.RecruitingExtranodal NK/T-cell LymphomaKorea, Republic of
-
The Thai Lymphoma Study GroupTakedaCompletedExtranodal NK/T-cell LymphomaThailand
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Small Lymphocytic Lymphoma | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Anaplastic Large Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
Versailles HospitalRecruitingT-cell Acute Lymphoblastic Leukemia | Relapsed/Refractory Acute Lymphoblastic LeukemiaFrance
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Oleg E. Akilov, MD, PhDMallinckrodtRecruiting
-
Northwestern UniversityRecruitingMycosis FungoidesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...ActelionWithdrawn
-
Stanford UniversityNational Institutes of Health (NIH)Withdrawn
-
Angimmune LLCUniversity of Colorado, Denver; Washington University School of Medicine; Yale... and other collaboratorsUnknown
-
M.D. Anderson Cancer CenterCompletedLymphomaUnited States